Literature DB >> 11960512

Management of croup.

Wendy Stannard1, Chris O'Callaghan.   

Abstract

Croup, or laryngotracheobronchitis, is a common childhood illness most often caused by viral infections. It is usually a benign, self-limiting disease, but can result in life-threatening upper airway obstruction. Until recently, it was not uncommon for children with severe croup to be admitted to intensive care for intubation. Management used to be limited to supportive measures, including mist therapy. The use of corticosteroids in patients with croup was controversial for many years but has, in the last decade, transformed the management of this disorder. Although corticosteroids do not alter the history of the viral infection, an adequate dose of oral or parenteral dexamethasone or nebulized budesonide has been shown to have a beneficial effect on the symptoms of croup.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960512     DOI: 10.2165/00128072-200204040-00003

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  61 in total

1.  Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing.

Authors:  K K Rittichier; C A Ledwith
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Children with croup presenting with scalds.

Authors:  P Greally; K Cheng; M S Tanner; D J Field
Journal:  BMJ       Date:  1990-07-14

3.  Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing.

Authors:  J M Fogel; I J Berg; M A Gerber; C B Sherter
Journal:  J Pediatr       Date:  1982-12       Impact factor: 4.406

Review 4.  Croup.

Authors:  G C Geelhoed
Journal:  Pediatr Pulmonol       Date:  1997-05

5.  Placebo-controlled trial of prednisolone in children intubated for croup.

Authors:  J Tibballs; F A Shann; L I Landau
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

6.  Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study.

Authors:  S Husby; L Agertoft; S Mortensen; S Pedersen
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

Review 7.  Croup.

Authors:  N Skolnik
Journal:  J Fam Pract       Date:  1993-08       Impact factor: 0.493

8.  Racemic epinephrine use in croup and disposition.

Authors:  P B Kelley; J E Simon
Journal:  Am J Emerg Med       Date:  1992-05       Impact factor: 2.469

9.  Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial.

Authors:  T P Klassen; W R Craig; D Moher; M H Osmond; H Pasterkamp; T Sutcliffe; L K Watters; P C Rowe
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup.

Authors:  C A Ledwith; L M Shea; R D Mauro
Journal:  Ann Emerg Med       Date:  1995-03       Impact factor: 5.721

View more
  1 in total

Review 1.  Communication between Bacteria and Their Hosts.

Authors:  Primrose Freestone
Journal:  Scientifica (Cairo)       Date:  2013-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.